End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-15 pm EDT
5-day change
1st Jan Change
18.39
CNY
+0.27%
+1.60%
-43.07%
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million.
The company closed its plan on March 11, 2024.
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves the Cash Dividend for the Year 2023
May. 14
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 25
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Apr. 21
CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Mar. 21
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million.
Mar. 10
CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
Jan. 02
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-22
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-28
CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
23-07-02
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023
23-06-28
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 26, 2023.
23-06-05
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Cash Dividend for the Year 2022
23-05-17
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-25
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Proposes Final Cash Dividend for 2022
23-04-24
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-23
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-24
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-29
CI
Chongqing Fuling Sanhai Lanling Co., Ltd. announced that it expects to receive CNY 576.3965 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
22-07-20
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 07 June 2022
22-05-27
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021
22-05-23
CI
Jiangsu Hualan New Pharma to List 1.8 Million Shares Post IPO Lock-Up Period
22-05-08
MT
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-28
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Profit Distribution Proposal for 2021
22-04-25
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-24
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Executive Changes
22-03-23
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Jiangsu Hualan New Pharmaceutical Material Co Ltd is a China-based company primarily engaged in the research, development, production and sales of packaging materials for direct contact injection drugs. The Companyâs main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The Company's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The Company also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The Company distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.
More about the company
Last Close Price
18.39
CNY
Average target price
28.82
CNY
Spread / Average Target
+56.72%
Consensus
1st Jan change
Capi.
-43.07% 325M +5.33% 27.06B +15.32% 6B +80.19% 4.22B +2.47% 3.44B -10.66% 3.32B -16.55% 3.26B +21.29% 2.92B +3.20% 2.67B +6.91% 2.49B
Other Tires & Rubber Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1